Why the study?
To evaluate the relationship between pericoronary FAI, markers of inflammation and extracellular matrix remodeling, and CTCA vulnerable plaque criteria in ACS patients.
Does pericoronary fat attenuation index (FAI) correlate with vulnerable plaque characteristics and inflammation markers in patients with acute coronary syndrome?
Population
72 ACS patients undergoing PCI with plaques <50% stenosis
Comparison
Pericoronary FAI across vulnerable plaque criteria and biomarker levels
Design
Prospective single-center study within a clinical trial
Follow-up
12 months
Authors
Loading...
FAI may signal vulnerable plaques and inflammation post-ACS; leaves open its role in risk stratification or management.
Does pericoronary fat attenuation index (FAI) correlate with vulnerable plaque characteristics and inflammation markers in patients with acute coronary syndrome?
Pericoronary fat attenuation index assessed by CTCA correlates with vulnerable plaque characteristics and systemic inflammation markers in patients recovering from acute coronary syndrome.
Kovalskaya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: